Mhc class i defectD81.6

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 20.03.2022

Dieser Artikel auf Deutsch

Synonym(s)

Bare Lymphocyte Syndromes; BLS; MHC class I deficiency; MHC I- expression defect

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Very rare (< 20 patients described worldwide), autosomal recessive mutations in the TAP1 - TAP2 or TAPBP gene(TAP = transporter associated with antigen processing), leading to defective HLA expression, and thus to a complex disorder of MHC-dominated antigen presentation or immune response (see also Immunodeficiencies/s.a. MHC class II defect).

EtiopathogenesisThis section has been translated automatically.

The genes for the human HLA system are located on the short arm of chromosome 6 and the gene products play a central role in adaptive immunity with the presentation of peptides for their recognition by T cells. An intact MHC class I expression is also necessary for the physiological maturation of CD8-positive T cells. The gene products of TAP are integrated in the membrane of the endoplasmic reticulum (ER). They protrude into the cytosol with a transmembrane domain. These are relevant for both substrate and ATP binding. The TAP protein causes the transport of antigenic peptides from the cytosol into the endoplasmic reticulum. There they are coupled with MHC class I molecules and can be presented to the T-lymphocytes as MHC antigen complex. Pathogenetically, this disturbance leads to an incorrect processing of the antigen presentation.

ManifestationThis section has been translated automatically.

Childhood, more rarely only in adulthood.

Clinical featuresThis section has been translated automatically.

Recurrent bacterial infections of the upper and lower respiratory tract. In the late stage, these lead to destruction of the airways with bronchiectasis.

Granulomatous, even necrotizing lesions of the skin and airways occur in 50% of patients and resemble Wegener's disease in clinical expression. Patients with TAP-2 mutations usually have more severe disease than those with TAP1 mutations.

General therapyThis section has been translated automatically.

Symptomatically adapted to the infection situation.

LiteratureThis section has been translated automatically.

  1. Cerundolo V et al (2006) Description of HLA class I- and CD8-deficient patients: Insights into the function of cytotoxic T lymphocytes and NK cells in host defense. Semin Immunol 18: 330-336
  2. de la Calle-Martin O et al (2001) Familial CD8 deficiency due to a mutation in the CD8 alpha gene. J Clin Invest 108: 117-123
  3. Hauber I et al (1996) More on MHC class II deficiency. N Engl J Med 335: 977-978
  4. Klein C et al (1993) Major Histocompatibility Complex class II deficiency - clinical manifestation, immunologic features and outcome. J Pediatr 123: 921-928
  5. Reith W et al (2001) The bare lymphocyte syndrome and the regulation of MHC expression. Annu Rev Immunol 19: 331-373

Authors

Last updated on: 20.03.2022